3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
5
Lymphoma
4
Breast Neoplasms
4
Ovarian Neoplasms
3
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Endometrial Neoplasms
3
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Colonic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid cancer, follicular
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma, Mantle-Cell
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Cyclophosphamide
12
Biopsy
10
Specimen Handling
9
Whole-Body Irradiation
7
Magnetic Resonance Spectroscopy
7
pembrolizumab
6
Peripheral Blood Stem Cell Transplantation
6
Melphalan
6
Etoposide
6
fludarabine
5
duvelisib
5
Brentuximab Vedotin
5
ruxolitinib
4
fludarabine phosphate
4
Vincristine
4
Prednisone
4
Doxorubicin
4
Cytarabine
4
10-propargyl-10-deazaaminopterin
4
romidepsin
3
X-Rays
3
Mycophenolic Acid
3
Immunoglobulin G
3
Granulocyte Colony-Stimulating Factor
3
Gemcitabine
3
Disulfides
3
Carmustine
3
venetoclax
2
tazemetostat
2
sodium-iodide symporter
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
copanlisib
×
1 year
×
Clear all
No trials found.